FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308695917> ?p ?o ?g. }

• W4308695917 endingPage "858" @default.
• W4308695917 startingPage "848" @default.
• W4308695917 abstract "Previous studies of type 1 diabetes in childhood and adolescence have found large variations in reported incidence around the world. However, it is unclear whether these reported incidence levels are impacted by differences in country health systems and possible underdiagnosis and if so, to what degree. The aim of this study was to estimate both the total and diagnosed incidence of type 1 diabetes globally and to project childhood type 1 diabetes incidence indicators from 1990 to 2050 for each country.We developed the type 1 diabetes global microsimulation model to simulate the natural history and diagnosis of type 1 diabetes for children and adolescents (aged 0-19 years) in 200 countries and territories, accounting for variability in underlying incidence and health system performance. The model follows an open population of children and adolescents in monthly intervals and simulates type 1 diabetes incidence and progression, as well as health system factors which influence diagnosis. We calibrated the model to published data on type 1 diabetes incidence, autoantibody profiles, and proportion of cases diagnosed with diabetic ketoacidosis from 1990 to 2020 and assessed the predictive accuracy using a randomly sampled test set of data withheld from calibration.We estimate that in 2021 there were 355 900 (95% UI 334 200-377 300) total new cases of type 1 diabetes globally among children and adolescents, of which 56% (200 400 cases, 95% UI 180 600-219 500) were diagnosed. Estimated underdiagnosis varies substantially by region, with over 95% of new cases diagnosed in Australia and New Zealand, western and northern Europe, and North America, but less than 35% of new cases diagnosed in west Africa, south and southeastern Asia, and Melanesia. The total number of incident childhood cases of type 1 diabetes is projected to increase to 476 700 (95% UI 449 500-504 300) in 2050.Our research indicates that the total global incidence of childhood and adolescent type 1 diabetes is larger than previously estimated, with nearly one-in-two children currently undiagnosed. Policymakers should plan for adequate diagnostic and medical capacity to improve timely type 1 diabetes detection and treatment, particularly as incidence is projected to increase worldwide, with highest numbers of new cases in Africa.Novo Nordisk." @default.
• W4308695917 created "2022-11-14" @default.
• W4308695917 creator A5004694923 @default.
• W4308695917 creator A5016953855 @default.
• W4308695917 creator A5024024220 @default.
• W4308695917 creator A5029145903 @default.
• W4308695917 creator A5030161393 @default.
• W4308695917 creator A5036133840 @default.
• W4308695917 creator A5038726864 @default.
• W4308695917 creator A5038729212 @default.
• W4308695917 creator A5040941938 @default.
• W4308695917 creator A5044406466 @default.
• W4308695917 creator A5049399234 @default.
• W4308695917 creator A5049615215 @default.
• W4308695917 creator A5051548595 @default.
• W4308695917 creator A5055188572 @default.
• W4308695917 creator A5056740916 @default.
• W4308695917 creator A5057245327 @default.
• W4308695917 creator A5060349132 @default.
• W4308695917 creator A5061390399 @default.
• W4308695917 creator A5062054049 @default.
• W4308695917 creator A5067301150 @default.
• W4308695917 creator A5071192542 @default.
• W4308695917 creator A5073136182 @default.
• W4308695917 creator A5075328230 @default.
• W4308695917 creator A5078132125 @default.
• W4308695917 creator A5079989065 @default.
• W4308695917 creator A5085183316 @default.
• W4308695917 creator A5086117936 @default.
• W4308695917 creator A5090105475 @default.
• W4308695917 creator A5072632441 @default.
• W4308695917 date "2022-12-01" @default.
• W4308695917 modified "2023-10-10" @default.
• W4308695917 title "Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis" @default.
• W4308695917 cites W1593597088 @default.
• W4308695917 cites W1965454656 @default.
• W4308695917 cites W2026454163 @default.
• W4308695917 cites W2033809694 @default.
• W4308695917 cites W2040088666 @default.
• W4308695917 cites W2095256598 @default.
• W4308695917 cites W2123412381 @default.
• W4308695917 cites W2200741680 @default.
• W4308695917 cites W2407801685 @default.
• W4308695917 cites W2530531915 @default.
• W4308695917 cites W2556192365 @default.
• W4308695917 cites W2616392142 @default.
• W4308695917 cites W2789327555 @default.
• W4308695917 cites W2886433380 @default.
• W4308695917 cites W2898504466 @default.
• W4308695917 cites W2912769950 @default.
• W4308695917 cites W2912804279 @default.
• W4308695917 cites W2946188513 @default.
• W4308695917 cites W3018568543 @default.
• W4308695917 cites W3137888669 @default.
• W4308695917 cites W4200221460 @default.
• W4308695917 cites W4210515214 @default.
• W4308695917 cites W4211168619 @default.
• W4308695917 cites W4212929519 @default.
• W4308695917 cites W4256127771 @default.
• W4308695917 cites W4296162804 @default.
• W4308695917 doi "https://doi.org/10.1016/s2213-8587(22)00276-5" @default.
• W4308695917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36372070" @default.
• W4308695917 hasPublicationYear "2022" @default.
• W4308695917 type Work @default.
• W4308695917 citedByCount "15" @default.
• W4308695917 countsByYear W43086959172022 @default.
• W4308695917 countsByYear W43086959172023 @default.
• W4308695917 crossrefType "journal-article" @default.
• W4308695917 hasAuthorship W4308695917A5004694923 @default.
• W4308695917 hasAuthorship W4308695917A5016953855 @default.
• W4308695917 hasAuthorship W4308695917A5024024220 @default.
• W4308695917 hasAuthorship W4308695917A5029145903 @default.
• W4308695917 hasAuthorship W4308695917A5030161393 @default.
• W4308695917 hasAuthorship W4308695917A5036133840 @default.
• W4308695917 hasAuthorship W4308695917A5038726864 @default.
• W4308695917 hasAuthorship W4308695917A5038729212 @default.
• W4308695917 hasAuthorship W4308695917A5040941938 @default.
• W4308695917 hasAuthorship W4308695917A5044406466 @default.
• W4308695917 hasAuthorship W4308695917A5049399234 @default.
• W4308695917 hasAuthorship W4308695917A5049615215 @default.
• W4308695917 hasAuthorship W4308695917A5051548595 @default.
• W4308695917 hasAuthorship W4308695917A5055188572 @default.
• W4308695917 hasAuthorship W4308695917A5056740916 @default.
• W4308695917 hasAuthorship W4308695917A5057245327 @default.
• W4308695917 hasAuthorship W4308695917A5060349132 @default.
• W4308695917 hasAuthorship W4308695917A5061390399 @default.
• W4308695917 hasAuthorship W4308695917A5062054049 @default.
• W4308695917 hasAuthorship W4308695917A5067301150 @default.
• W4308695917 hasAuthorship W4308695917A5071192542 @default.
• W4308695917 hasAuthorship W4308695917A5072632441 @default.
• W4308695917 hasAuthorship W4308695917A5073136182 @default.
• W4308695917 hasAuthorship W4308695917A5075328230 @default.
• W4308695917 hasAuthorship W4308695917A5078132125 @default.
• W4308695917 hasAuthorship W4308695917A5079989065 @default.
• W4308695917 hasAuthorship W4308695917A5085183316 @default.
• W4308695917 hasAuthorship W4308695917A5086117936 @default.
• W4308695917 hasAuthorship W4308695917A5090105475 @default.
• W4308695917 hasConcept C120665830 @default.

• next